About Spiral Therapeutics
Spiral Therapeutics is a private company based in South San Francisco, California. It has reported $46,469,478 raised in three offerings on Form D since December 2018. Its chief executive is Hugo Peris.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 30, 2025 | Apr 16, 2026 | $27,089,839of $27.0M target | 34 | $796K | EquityRule 506(b) | Form D ↗ |
| Oct 18, 2022 | Dec 2, 2022amended Feb 7, 2023 | $10,904,985fully sold | 48 | $227K | Equity, (i)Sale/issue of Ser A-4 Pref Stk, (ii)Ser A-5 Pref Stk, (iii)warrants to purchase Ser A-5 Pref Stk, (iv)Ser A-5 Pref Stk issuable upon exercise of the warrants, and (v)Common Stk issuable upon conversion of Ser A-4 Pref Stk and Ser A-5 Pref Stk.Rule 506(b) | Form D/A ↗1 earlier filing |
| Dec 10, 2018 | Dec 19, 2018 | $8,474,654of $12.9M target | 38 | $223K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $46,469,478 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Spiral Therapeutics's Form D filed Apr 16, 2026.
WT
Warren Thaler
Director
Eugene De Juan
Executive Chairman
Anthony Adamis
Independent and director
FG
Frederic Guerard
Director
Also a director at Lenz Therapeutics and a president and chief executive officer, director at Qlaris Bio.
Jean-Frederic Paulsen
Ferring Ventures SA and director
GG
Guy Jean Savoir Garcia
Director
Diamantis Xylas
Catalio Capital and director
Angela Macfarlane
Independent and director
Earlier filings also listed Guy P. Nohra (director, last listed Feb 2023), Lawrence Fritz (director, last listed Dec 2018) and Guy Jean Savoir Garcia (director, last listed Dec 2018).
Sources
- SECSpiral Therapeutics Inc Form D, filed Dec 2, 2022
- SECSpiral Therapeutics Inc filing history
- CompanyContact
- CompanyAbout
- CompanyTeam